Precision or personalized medicine is currently gaining a lot of attention. Clinical evidence
for its effectiveness has been established based on randomized clinical trials accounting for …

Genetic variants are major determinants of susceptibility to disease, response to therapy,
and clinical outcomes. Advances in the short-read sequencing technologies, despite some …

Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide and also
inflict major burdens on morbidity, quality of life, and societal costs. Considering that CVD …

New biomarker strategies to enable precision cardiovascular... : Current Opinion in Cardiology
New biomarker strategies to enable precision cardiovascular medicine : Current Opinion in …

Cardiovascular diseases remain the dominant cause of death worldwide. In the last
decades, the remarkable advances in human genetic and genomic research, plus the now …

Atherosclerosis and its clinical manifestations is a leading cause of disease burden
worldwide. Currently, most of the individuals carrying a strong predisposition to …

Cardiovascular disease (CVD) is the leading cause of death in the world. Over the past
decade considerable progress has been made in understanding the genomic basis of …

Precision medicine strives to delineate disease using multiple data sources—from genomics
to digital health metrics—in order to be more precise and accurate in our diagnoses …

Despite the rapid progress in diagnosis and treatment of cardiovascular disease (CVD), this
disease remains a major cause of mortality and morbidity. Recent progress over the last two …

Cardiovascular disease (CVD) is a heterogeneous, complex trait that has a major impact on
human morbidity and mortality. Common genetic variation may predispose to common forms …